Evaluation of a nationwide Dutch guideline to detect Lynch syndrome in patients with endometrial cancer

Autor: K. Schelfhout, H.P.M. Smedts, A.A.M. van der Wurff, Anja Wagner, R.A. Smit, W. Dinjens, L. Hofman, A.S. Tjalsma, M.E.R. de Groot, Luthy S.M. Alcala, A.C. van Hof, P.J. Timmers, Patricia C. Ewing-Graham, B.A.J.T. Visschers, W. Hofhuis, H. C. van Doorn, K.E. Hamoen, K.J. Hoogduin, A.C.F. Makkus, S.J.J. Mol, G.M. Plaisier, P.M.L.H. Vencken, J. Kaijser

Publikováno v: Gynecologic Oncology, 160(3), 771-776. Academic Press

Objective: In the Netherlands a nationwide guideline was introduced in 2016, which recommended routine Lynch syndrome screening (LSS) for all women with endometrial cancer (EC)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::720844fcc6ca13ec30fe22eba65d1abc
http://www.scopus.com/inward/record.url?scp=85098892154&partnerID=8YFLogxK

Clinical auditing as an instrument to improve care for patients with ovarian cancer

Autor: N. Leffers, H.T.C. Nagel, Roy F.P.M. Kruitwagen, R.A. Smit, F.A. Ten Cate, A.D. Ten Cate, S.F.P.J. Coppus, A.M.L.D. Van Haaften-de Jong, J.H.A. Vollebergh, M.J.A. Engelen, Eva Maria Roes, L.C. De Vries, P.J. Timmers, E.A. Ooms, J. Diepstraten, G.H. Jansen, W. Minderhoud-Bassie, N.M.S. Baldewpersad Tewarie, M.I. Baas, M.A. van der Aa, M. van Ham, A.J. Kruse, T.K. Schikken, T.C. Stam, I.M.W. Ebisch, J.A. Louwers, J.W. Mens, A.M.G. van de Swaluw, E. Davelaar, C.G. Gerestein, M.W. Glas, R. van de Laar, B.A.J.T. Visschers, H.P.M. Smedts, W.J. van Driel, E.B.L. van Dorst, R. Yigit, M.W.G. Moonen Delarue, W.M. van Baal, Y.W.C.M. Van der Plas – Koning, M.Y. Tjiong, L.R. Bartelink, F.M.F. Rosier-van Dunné, M.B. Verbruggen, J.G. Lange, Michel W.J.M. Wouters, C.M.W.H. Smeets, G. Fons, F.E.M. Rijcken, H.R. Verhoeve, J.W.D. de Waard, E.J.M. Van Es, J.E.W. Van Dijk, J. Briet, C.C.M. Buis, K. Overmars, A. van der Kolk, M. Kleppe, M.A. Huisman, P. Kolk, E.J.M. Robbe, M. van den Hende, M. Huisman, Brigitte F. M. Slangen, A.L. Aalders, S.M. Westenberg, H.H. Keizer, M.C. Vos, A. Baalbergen, L.N. Hofman, J. Kaijser, D. Boll, N. Reesink, D. Boskamp, P.M.L.H. Vencken, K.N. Gaarenstroom, D.H. Ngo, M.D. Wust

Publikováno v: European Journal of Surgical Oncology, 47(7), 1691-1697. W.B. Saunders
European Journal of Surgical Oncology, 47, 7, pp. 1691-1697
European Journal of Surgical Oncology, 47, 1691-1697
European Journal of Surgical Oncology, 47(7), 1691-1697. ELSEVIER SCI LTD
European Journal of Surgical Oncology, 47(7), 1691-1697. W.B. Saunders Ltd
European journal of surgical oncology, 47(7), 1691-1697. W.B. Saunders Ltd
EJSO-European Journal of Surgical Oncology, 47(7), 1691-1697. ELSEVIER SCI LTD
participants of the Dutch Gynecological Oncology Collaborator Group 2021, ' Clinical auditing as an instrument to improve care for patients with ovarian cancer: The Dutch Gynecological Oncology Audit (DGOA) ', European Journal of Surgical Oncology, vol. 47, no. 7, pp. 1691-1697 . https://doi.org/10.1016/j.ejso.2021.01.019

Introduction: The Dutch Gynecological Oncology Audit (DGOA) was initiated in 2014 to serve as a nationwide audit, which registers the four most prevalent gynecological malignancies. This study presents the first results of clinical auditing for ovari

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05397eadfd4449c5d34008662c18454f
https://hdl.handle.net/1887/3276128

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers

Autor: Luc R.C.W. van Lonkhuijzen, P.M.L.H. Vencken, Marc van Beurden, Caroline Seynaeve, Leendert H. Zaaijer, Joanne A. de Hullu, Ronald P. Zweemer, Marian J.E. Mourits, Brigitte F. M. Slangen, Hans F. A. Vasen, Muriel A. Adank, Mieke Kriege, Helena C. van Doorn, Katja N. Gaarenstroom

Publikováno v: British Jounal of Cancer, 115(10), 1174-1178. Nature Publishing Group
British Journal of Cancer, 115, 10, pp. 1174-1178
British Journal of Cancer, 115(10), 1174-1178. Nature Publishing Group
Zaaijer, L H, Van Doorn, H C, Mourits, M J E, van Beurden, M, de Hullu, J A, Adank, M A, van Lonkhuijzen, L R C W, Vasen, H F A, Slangen, B F M, Gaarenstroom, K N, Zweemer, R P, Vencken, P M L H, Seynaeve, C & Kriege, M 2016, ' Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers ', British Journal of Cancer, vol. 115, no. 10, pp. 1174-1178 . https://doi.org/10.1038/bjc.2016.333
British Journal of Cancer
British Journal of Cancer, 115, 1174-1178
British journal of cancer, 115(10), 1174-1178. Nature Publishing Group
British Journal of Cancer, 115(10), 1174-1178

Contains fulltext : 171109.pdf (Publisher’s version ) (Open Access) BACKGROUND: It is unknown whether a history of breast cancer (BC) affects the outcome of BRCA1/2-associated epithelial ovarian cancer (EOC). This was investigated in the current an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7bac045b2eaf71f4778c5fff40da6a
https://research.rug.nl/en/publications/10a9b997-872b-4519-8a67-bfba837eaf62

Conservative management in breech deliveries leads to similar results compared with cephalic deliveries

Autor: S.E. Buitendijk, Frans J.M.E. Roumen, P.M.L.H. Vencken, Jan G. Nijhuis, J.F.M. Molkenboer, F. Smits, L.G.J. Sonnemans

Publikováno v: Journal of Maternal-Fetal and Neonatal Medicine, 8, 20, 599-603
journal of maternal-fetal & neonatal medicine, 20(8), 599-603. Informa Healthcare

Objective. To compare the difference in neonatal mortality and morbidity between breech and cephalic presentations at term. Methods. This was a retrospective matched cohort study in two centers between July 1998 and April 2000, including all breech d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b38f4a9d60cab9f5375411de26a2606
https://pubmed.ncbi.nlm.nih.gov/17674277

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.